APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABA Receptor Agonist Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global GABA Receptor Agonist Drug Industry Growth and Trends Forecast to 2032

22 December 2025115 pages

Choose your research edition.

Industry ResearchGABA Receptor Agonist Drug Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal GABA Receptor Agonist Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal GABA Receptor Agonist Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABA Receptor Agonist Drug Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal GABA Receptor Agonist Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global GABA Receptor Agonist Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for GABA Receptor Agonist Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for GABA Receptor Agonist Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GABA Receptor Agonist Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GABA Receptor Agonist Drug include Novartis, Eli Lilly and Company, Pfizer, GlaxoSmithKline, AstraZeneca, XenoPort, VIVUS, sanofi-aventis and OVATION Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global GABA Receptor Agonist Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The GABA Receptor Agonist Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global GABA Receptor Agonist Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to GABA Receptor Agonist Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global GABA Receptor Agonist Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

GABA Receptor Agonist Drug Market by Company

Novartis

Eli Lilly and Company

Pfizer

GlaxoSmithKline

AstraZeneca

XenoPort

VIVUS

sanofi-aventis

OVATION Pharmaceuticals

Osmotica Pharmaceutical

NovaDel Pharma

H.LundBeck, Merck and Co

Elan Corporation

Biocodex

Athena Drug Delivery Solutions

Advicenne

GABA Receptor Agonist Drug Segment by Type

Baclofen

Bamaluzole

Phenibut

Gaboxadol

Klonopin (clonazepam)

Tiagbine

GABA Receptor Agonist Drug Segment by Application

Alzheimer

Epilepsy and Seizure

Obesity and Alcoholism

Anxiety and Sleep Disorders

Psychiatric Disorders and Depression

Attention Deficit Hyperactivity Disorder (ADHD)

GABA Receptor Agonist Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA Receptor Agonist Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABA Receptor Agonist Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA Receptor Agonist Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GABA Receptor Agonist Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of GABA Receptor Agonist Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Baclofen Table 2. Major Company of Bamaluzole Table 3. Major Company of Phenibut Table 4. Major Company of Gaboxadol Table 5. Major Company of Klonopin (clonazepam) Table 6. Major Company of Tiagbine Table 7. Global GABA Receptor Agonist Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 9. Global GABA Receptor Agonist Drug Sales Market Share in Volume by Type (2021-2026) Table 10. Global GABA Receptor Agonist Drug Sales by Type (2021-2026) & (US$ Million) Table 11. Global GABA Receptor Agonist Drug Sales Market Share in Value by Type (2021-2026) Table 12. Global GABA Receptor Agonist Drug Price by Type (2021-2026) & (US$/unit) Table 13. Global GABA Receptor Agonist Drug Sales by Type (2027-2032) & (k units) Table 14. Global GABA Receptor Agonist Drug Sales Market Share in Volume by Type (2027-2032) Table 15. Global GABA Receptor Agonist Drug Sales by Type (2027-2032) & (US$ Million) Table 16. Global GABA Receptor Agonist Drug Sales Market Share in Value by Type (2027-2032) Table 17. Global GABA Receptor Agonist Drug Price by Type (2027-2032) & (US$/unit) Table 18. North America GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 19. North America GABA Receptor Agonist Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Europe GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 21. Europe GABA Receptor Agonist Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific GABA Receptor Agonist Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 25. Latin America GABA Receptor Agonist Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa GABA Receptor Agonist Drug Sales by Type (2021-2026) & (US$ Million) Table 28. GABA Receptor Agonist Drug Industry Trends Table 29. GABA Receptor Agonist Drug Industry Drivers Table 30. GABA Receptor Agonist Drug Industry Opportunities and Challenges Table 31. GABA Receptor Agonist Drug Industry Restraints Table 32. Global GABA Receptor Agonist Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global GABA Receptor Agonist Drug Revenue Market Share by Company (2021-2026) Table 34. Global GABA Receptor Agonist Drug Sales by Company (2021-2026) & (k units) Table 35. Global GABA Receptor Agonist Drug Sales Share by Company (2021-2026) Table 36. Global GABA Receptor Agonist Drug Market Price by Company (2021-2026) & (US$/unit) Table 37. Global GABA Receptor Agonist Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global GABA Receptor Agonist Drug Major Company Production Sites and Headquarters Table 39. Global GABA Receptor Agonist Drug Company, Product Type & Application Table 40. Global GABA Receptor Agonist Drug Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global GABA Receptor Agonist Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global GABA Receptor Agonist Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global GABA Receptor Agonist Drug Sales by Region (2021-2026) & (k units) Table 45. Global GABA Receptor Agonist Drug Sales Market Share in Volume by Region (2021-2026) Table 46. Global GABA Receptor Agonist Drug Sales by Region (2021-2026) & (US$ Million) Table 47. Global GABA Receptor Agonist Drug Sales Market Share in Value by Region (2021-2026) Table 48. Global GABA Receptor Agonist Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 49. Global GABA Receptor Agonist Drug Sales by Region (2027-2032) & (k units) Table 50. Global GABA Receptor Agonist Drug Sales Market Share in Volume by Region (2027-2032) Table 51. Global GABA Receptor Agonist Drug Sales by Region (2027-2032) & (US$ Million) Table 52. Global GABA Receptor Agonist Drug Sales Market Share in Value by Region (2027-2032) Table 53. Global GABA Receptor Agonist Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 54. Global GABA Receptor Agonist Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 56. Global GABA Receptor Agonist Drug Sales Market Share in Volume by Application (2021-2026) Table 57. Global GABA Receptor Agonist Drug Sales by Application (2021-2026) & (US$ Million) Table 58. Global GABA Receptor Agonist Drug Sales Market Share in Value by Application (2021-2026) Table 59. Global GABA Receptor Agonist Drug Price by Application (2021-2026) & (US$/unit) Table 60. Global GABA Receptor Agonist Drug Sales by Application (2027-2032) & (k units) Table 61. Global GABA Receptor Agonist Drug Sales Market Share in Volume by Application (2027-2032) Table 62. Global GABA Receptor Agonist Drug Sales by Application (2027-2032) & (US$ Million) Table 63. Global GABA Receptor Agonist Drug Sales Market Share in Value by Application (2027-2032) Table 64. Global GABA Receptor Agonist Drug Price by Application (2027-2032) & (US$/unit) Table 65. North America GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 66. North America GABA Receptor Agonist Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Europe GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 68. Europe GABA Receptor Agonist Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific GABA Receptor Agonist Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 72. Latin America GABA Receptor Agonist Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa GABA Receptor Agonist Drug Sales by Application (2021-2026) & (US$ Million) Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Novartis GABA Receptor Agonist Drug Product Portfolio Table 79. Novartis Recent Development Table 80. Eli Lilly and Company Company Information Table 81. Eli Lilly and Company Business Overview Table 82. Eli Lilly and Company GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Eli Lilly and Company GABA Receptor Agonist Drug Product Portfolio Table 84. Eli Lilly and Company Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Pfizer GABA Receptor Agonist Drug Product Portfolio Table 89. Pfizer Recent Development Table 90. GlaxoSmithKline Company Information Table 91. GlaxoSmithKline Business Overview Table 92. GlaxoSmithKline GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. GlaxoSmithKline GABA Receptor Agonist Drug Product Portfolio Table 94. GlaxoSmithKline Recent Development Table 95. AstraZeneca Company Information Table 96. AstraZeneca Business Overview Table 97. AstraZeneca GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. AstraZeneca GABA Receptor Agonist Drug Product Portfolio Table 99. AstraZeneca Recent Development Table 100. XenoPort Company Information Table 101. XenoPort Business Overview Table 102. XenoPort GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. XenoPort GABA Receptor Agonist Drug Product Portfolio Table 104. XenoPort Recent Development Table 105. VIVUS Company Information Table 106. VIVUS Business Overview Table 107. VIVUS GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. VIVUS GABA Receptor Agonist Drug Product Portfolio Table 109. VIVUS Recent Development Table 110. sanofi-aventis Company Information Table 111. sanofi-aventis Business Overview Table 112. sanofi-aventis GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. sanofi-aventis GABA Receptor Agonist Drug Product Portfolio Table 114. sanofi-aventis Recent Development Table 115. OVATION Pharmaceuticals Company Information Table 116. OVATION Pharmaceuticals Business Overview Table 117. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Portfolio Table 119. OVATION Pharmaceuticals Recent Development Table 120. Osmotica Pharmaceutical Company Information Table 121. Osmotica Pharmaceutical Business Overview Table 122. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Portfolio Table 124. Osmotica Pharmaceutical Recent Development Table 125. NovaDel Pharma Company Information Table 126. NovaDel Pharma Business Overview Table 127. NovaDel Pharma GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. NovaDel Pharma GABA Receptor Agonist Drug Product Portfolio Table 129. NovaDel Pharma Recent Development Table 130. H.LundBeck, Merck and Co Company Information Table 131. H.LundBeck, Merck and Co Business Overview Table 132. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Portfolio Table 134. H.LundBeck, Merck and Co Recent Development Table 135. Elan Corporation Company Information Table 136. Elan Corporation Business Overview Table 137. Elan Corporation GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. Elan Corporation GABA Receptor Agonist Drug Product Portfolio Table 139. Elan Corporation Recent Development Table 140. Biocodex Company Information Table 141. Biocodex Business Overview Table 142. Biocodex GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 143. Biocodex GABA Receptor Agonist Drug Product Portfolio Table 144. Biocodex Recent Development Table 145. Athena Drug Delivery Solutions Company Information Table 146. Athena Drug Delivery Solutions Business Overview Table 147. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 148. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Portfolio Table 149. Athena Drug Delivery Solutions Recent Development Table 150. Advicenne Company Information Table 151. Advicenne Business Overview Table 152. Advicenne GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 153. Advicenne GABA Receptor Agonist Drug Product Portfolio Table 154. Advicenne Recent Development Table 155. North America GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 156. North America GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 157. North America GABA Receptor Agonist Drug Sales Market Share by Country (2021-2026) Table 158. North America GABA Receptor Agonist Drug Sales Forecast by Country (2027-2032) & (k units) Table 159. North America GABA Receptor Agonist Drug Sales Market Share Forecast by Country (2027-2032) Table 160. North America GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. North America GABA Receptor Agonist Drug Market Size by Country (2021-2026) & (US$ Million) Table 162. North America GABA Receptor Agonist Drug Market Share by Country (2021-2026) Table 163. North America GABA Receptor Agonist Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. North America GABA Receptor Agonist Drug Market Share Forecast by Country (2027-2032) Table 165. Europe GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 166. Europe GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 167. Europe GABA Receptor Agonist Drug Sales Market Share by Country (2021-2026) Table 168. Europe GABA Receptor Agonist Drug Sales Forecast by Country (2027-2032) & (k units) Table 169. Europe GABA Receptor Agonist Drug Sales Market Share Forecast by Country (2027-2032) Table 170. Europe GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Europe GABA Receptor Agonist Drug Market Size by Country (2021-2026) & (US$ Million) Table 172. Europe GABA Receptor Agonist Drug Market Share by Country (2021-2026) Table 173. Europe GABA Receptor Agonist Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Europe GABA Receptor Agonist Drug Market Share Forecast by Country (2027-2032) Table 175. Asia-Pacific GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 176. Asia-Pacific GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 177. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share by Country (2021-2026) Table 178. Asia-Pacific GABA Receptor Agonist Drug Sales Forecast by Country (2027-2032) & (k units) Table 179. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share Forecast by Country (2027-2032) Table 180. Asia-Pacific GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. Asia-Pacific GABA Receptor Agonist Drug Market Size by Country (2021-2026) & (US$ Million) Table 182. Asia-Pacific GABA Receptor Agonist Drug Market Share by Country (2021-2026) Table 183. Asia-Pacific GABA Receptor Agonist Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. Asia-Pacific GABA Receptor Agonist Drug Market Share Forecast by Country (2027-2032) Table 185. Latin America GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 186. Latin America GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 187. Latin America GABA Receptor Agonist Drug Sales Market Share by Country (2021-2026) Table 188. Latin America GABA Receptor Agonist Drug Sales Forecast by Country (2027-2032) & (k units) Table 189. Latin America GABA Receptor Agonist Drug Sales Market Share Forecast by Country (2027-2032) Table 190. Latin America GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 191. Latin America GABA Receptor Agonist Drug Market Size by Country (2021-2026) & (US$ Million) Table 192. Latin America GABA Receptor Agonist Drug Market Share by Country (2021-2026) Table 193. Latin America GABA Receptor Agonist Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 194. Latin America GABA Receptor Agonist Drug Market Share Forecast by Country (2027-2032) Table 195. Middle East and Africa GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 196. Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 197. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share by Country (2021-2026) Table 198. Middle East and Africa GABA Receptor Agonist Drug Sales Forecast by Country (2027-2032) & (k units) Table 199. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share Forecast by Country (2027-2032) Table 200. Middle East and Africa GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 201. Middle East and Africa GABA Receptor Agonist Drug Market Size by Country (2021-2026) & (US$ Million) Table 202. Middle East and Africa GABA Receptor Agonist Drug Market Share by Country (2021-2026) Table 203. Middle East and Africa GABA Receptor Agonist Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 204. Middle East and Africa GABA Receptor Agonist Drug Market Share Forecast by Country (2027-2032) Table 205. Key Raw Materials Table 206. Raw Materials Key Suppliers Table 207. GABA Receptor Agonist Drug Distributors List Table 208. GABA Receptor Agonist Drug Customers List Table 209. Research Programs/Design for This Report Table 210. Authors List of This Report Table 211. Secondary Sources Table 212. Primary Sources List of Figures Figure 1. GABA Receptor Agonist Drug Image Figure 2. Global GABA Receptor Agonist Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABA Receptor Agonist Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global GABA Receptor Agonist Drug Sales (2021-2032) & (k units) Figure 5. Baclofen Image Figure 6. Global Baclofen Sales YoY Growth (2021-2032) & (k units) Figure 7. Bamaluzole Image Figure 8. Global Bamaluzole Sales YoY Growth (2021-2032) & (k units) Figure 9. Phenibut Image Figure 10. Global Phenibut Sales YoY Growth (2021-2032) & (k units) Figure 11. Gaboxadol Image Figure 12. Global Gaboxadol Sales YoY Growth (2021-2032) & (k units) Figure 13. Klonopin (clonazepam) Image Figure 14. Global Klonopin (clonazepam) Sales YoY Growth (2021-2032) & (k units) Figure 15. Tiagbine Image Figure 16. Global Tiagbine Sales YoY Growth (2021-2032) & (k units) Figure 17. Global GABA Receptor Agonist Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global GABA Receptor Agonist Drug Market Share by Type 2025 VS 2032 Figure 19. North America GABA Receptor Agonist Drug Sales Market Share in Volume by Type in 2025 Figure 20. North America GABA Receptor Agonist Drug Sales Market Share in Value by Type in 2025 Figure 21. Europe GABA Receptor Agonist Drug Sales Market Share in Volume by Type in 2025 Figure 22. Europe GABA Receptor Agonist Drug Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share in Value by Type in 2025 Figure 25. Latin America GABA Receptor Agonist Drug Sales Market Share in Volume by Type in 2025 Figure 26. Latin America GABA Receptor Agonist Drug Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 GABA Receptor Agonist Drug Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Alzheimer Image Figure 32. Global Alzheimer Sales YoY Growth (2021-2032) & (k units) Figure 33. Epilepsy and Seizure Image Figure 34. Global Epilepsy and Seizure Sales YoY Growth (2021-2032) & (k units) Figure 35. Obesity and Alcoholism Image Figure 36. Global Obesity and Alcoholism Sales YoY Growth (2021-2032) & (k units) Figure 37. Anxiety and Sleep Disorders Image Figure 38. Global Anxiety and Sleep Disorders Sales YoY Growth (2021-2032) & (k units) Figure 39. Psychiatric Disorders and Depression Image Figure 40. Global Psychiatric Disorders and Depression Sales YoY Growth (2021-2032) & (k units) Figure 41. Attention Deficit Hyperactivity Disorder (ADHD) Image Figure 42. Global Attention Deficit Hyperactivity Disorder (ADHD) Sales YoY Growth (2021-2032) & (k units) Figure 43. Global GABA Receptor Agonist Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global GABA Receptor Agonist Drug Market Share by Application 2025 VS 2032 Figure 45. North America GABA Receptor Agonist Drug Sales Market Share in Volume by Application in 2025 Figure 46. North America GABA Receptor Agonist Drug Sales Market Share in Value by Application in 2025 Figure 47. Europe GABA Receptor Agonist Drug Sales Market Share in Volume by Application in 2025 Figure 48. Europe GABA Receptor Agonist Drug Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share in Value by Application in 2025 Figure 51. Latin America GABA Receptor Agonist Drug Sales Market Share in Volume by Application in 2025 Figure 52. Latin America GABA Receptor Agonist Drug Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share in Value by Application in 2025 Figure 55. North America GABA Receptor Agonist Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. North America GABA Receptor Agonist Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America GABA Receptor Agonist Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America GABA Receptor Agonist Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe GABA Receptor Agonist Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Europe GABA Receptor Agonist Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe GABA Receptor Agonist Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe GABA Receptor Agonist Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific GABA Receptor Agonist Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Asia-Pacific GABA Receptor Agonist Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific GABA Receptor Agonist Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific GABA Receptor Agonist Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America GABA Receptor Agonist Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Latin America GABA Receptor Agonist Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America GABA Receptor Agonist Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America GABA Receptor Agonist Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa GABA Receptor Agonist Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 72. Middle East and Africa GABA Receptor Agonist Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa GABA Receptor Agonist Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa GABA Receptor Agonist Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. GABA Receptor Agonist Drug Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. GABA Receptor Agonist Drug Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Baclofen
  • Bamaluzole
  • Phenibut
  • Gaboxadol
  • Klonopin (clonazepam)
  • Tiagbine
Applications
  • Alzheimer
  • Epilepsy and Seizure
  • Obesity and Alcoholism
  • Anxiety and Sleep Disorders
  • Psychiatric Disorders and Depression
  • Attention Deficit Hyperactivity Disorder (ADHD)
Companies covered
  • Novartis
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • XenoPort
  • VIVUS
  • sanofi-aventis
  • OVATION Pharmaceuticals
  • Osmotica Pharmaceutical
  • NovaDel Pharma
  • H.LundBeck, Merck and Co
  • Elan Corporation
  • Biocodex
  • Athena Drug Delivery Solutions
  • Advicenne

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GABA Receptor Agonist Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global GABA Receptor Agonist Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 GABA Receptor Agonist Drug Market by Type
  6. 1.3.1 Baclofen
  7. 1.3.2 Bamaluzole
  8. 1.3.3 Phenibut
  9. 1.3.4 Gaboxadol
  10. 1.3.5 Klonopin (clonazepam)
  11. 1.3.6 Tiagbine
  12. 1.4 Global GABA Receptor Agonist Drug Market Size by Type
  13. 1.4.1 Global GABA Receptor Agonist Drug Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global GABA Receptor Agonist Drug Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global GABA Receptor Agonist Drug Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America GABA Receptor Agonist Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe GABA Receptor Agonist Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific GABA Receptor Agonist Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America GABA Receptor Agonist Drug Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa GABA Receptor Agonist Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 GABA Receptor Agonist Drug Industry Trends
  2. 2.2 GABA Receptor Agonist Drug Industry Drivers
  3. 2.3 GABA Receptor Agonist Drug Industry Opportunities and Challenges
  4. 2.4 GABA Receptor Agonist Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by GABA Receptor Agonist Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by GABA Receptor Agonist Drug Sales (2021-2026)
  3. 3.3 Global Top Players by GABA Receptor Agonist Drug Price (2021-2026)
  4. 3.4 Global GABA Receptor Agonist Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GABA Receptor Agonist Drug Major Company Production Sites & Headquarters
  6. 3.6 Global GABA Receptor Agonist Drug Company, Product Type & Application
  7. 3.7 Global GABA Receptor Agonist Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GABA Receptor Agonist Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GABA Receptor Agonist Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GABA Receptor Agonist Drug Tier 1, Tier 2, and Tier 3
4 GABA Receptor Agonist Drug Regional Status and Outlook
  1. 4.1 Global GABA Receptor Agonist Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global GABA Receptor Agonist Drug Historic Market Size by Region
  3. 4.2.1 Global GABA Receptor Agonist Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global GABA Receptor Agonist Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global GABA Receptor Agonist Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global GABA Receptor Agonist Drug Forecasted Market Size by Region
  7. 4.3.1 Global GABA Receptor Agonist Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global GABA Receptor Agonist Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global GABA Receptor Agonist Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 GABA Receptor Agonist Drug by Application
  1. 5.1 GABA Receptor Agonist Drug Market by Application
  2. 5.1.1 Alzheimer
  3. 5.1.2 Epilepsy and Seizure
  4. 5.1.3 Obesity and Alcoholism
  5. 5.1.4 Anxiety and Sleep Disorders
  6. 5.1.5 Psychiatric Disorders and Depression
  7. 5.1.6 Attention Deficit Hyperactivity Disorder (ADHD)
  8. 5.2 Global GABA Receptor Agonist Drug Market Size by Application
  9. 5.2.1 Global GABA Receptor Agonist Drug Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global GABA Receptor Agonist Drug Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global GABA Receptor Agonist Drug Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America GABA Receptor Agonist Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe GABA Receptor Agonist Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific GABA Receptor Agonist Drug Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America GABA Receptor Agonist Drug Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa GABA Receptor Agonist Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis GABA Receptor Agonist Drug Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Eli Lilly and Company
  8. 6.2.1 Eli Lilly and Company Company Information
  9. 6.2.2 Eli Lilly and Company Business Overview
  10. 6.2.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly and Company GABA Receptor Agonist Drug Product Portfolio
  12. 6.2.5 Eli Lilly and Company Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer GABA Receptor Agonist Drug Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline GABA Receptor Agonist Drug Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca GABA Receptor Agonist Drug Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 XenoPort
  32. 6.6.1 XenoPort Company Information
  33. 6.6.2 XenoPort Business Overview
  34. 6.6.3 XenoPort GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 XenoPort GABA Receptor Agonist Drug Product Portfolio
  36. 6.6.5 XenoPort Recent Developments
  37. 6.7 VIVUS
  38. 6.7.1 VIVUS Company Information
  39. 6.7.2 VIVUS Business Overview
  40. 6.7.3 VIVUS GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 VIVUS GABA Receptor Agonist Drug Product Portfolio
  42. 6.7.5 VIVUS Recent Developments
  43. 6.8 sanofi-aventis
  44. 6.8.1 sanofi-aventis Company Information
  45. 6.8.2 sanofi-aventis Business Overview
  46. 6.8.3 sanofi-aventis GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 sanofi-aventis GABA Receptor Agonist Drug Product Portfolio
  48. 6.8.5 sanofi-aventis Recent Developments
  49. 6.9 OVATION Pharmaceuticals
  50. 6.9.1 OVATION Pharmaceuticals Company Information
  51. 6.9.2 OVATION Pharmaceuticals Business Overview
  52. 6.9.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Portfolio
  54. 6.9.5 OVATION Pharmaceuticals Recent Developments
  55. 6.10 Osmotica Pharmaceutical
  56. 6.10.1 Osmotica Pharmaceutical Company Information
  57. 6.10.2 Osmotica Pharmaceutical Business Overview
  58. 6.10.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Portfolio
  60. 6.10.5 Osmotica Pharmaceutical Recent Developments
  61. 6.11 NovaDel Pharma
  62. 6.11.1 NovaDel Pharma Company Information
  63. 6.11.2 NovaDel Pharma Business Overview
  64. 6.11.3 NovaDel Pharma GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 NovaDel Pharma GABA Receptor Agonist Drug Product Portfolio
  66. 6.11.5 NovaDel Pharma Recent Developments
  67. 6.12 H.LundBeck, Merck and Co
  68. 6.12.1 H.LundBeck, Merck and Co Company Information
  69. 6.12.2 H.LundBeck, Merck and Co Business Overview
  70. 6.12.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Portfolio
  72. 6.12.5 H.LundBeck, Merck and Co Recent Developments
  73. 6.13 Elan Corporation
  74. 6.13.1 Elan Corporation Company Information
  75. 6.13.2 Elan Corporation Business Overview
  76. 6.13.3 Elan Corporation GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Elan Corporation GABA Receptor Agonist Drug Product Portfolio
  78. 6.13.5 Elan Corporation Recent Developments
  79. 6.14 Biocodex
  80. 6.14.1 Biocodex Company Information
  81. 6.14.2 Biocodex Business Overview
  82. 6.14.3 Biocodex GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Biocodex GABA Receptor Agonist Drug Product Portfolio
  84. 6.14.5 Biocodex Recent Developments
  85. 6.15 Athena Drug Delivery Solutions
  86. 6.15.1 Athena Drug Delivery Solutions Company Information
  87. 6.15.2 Athena Drug Delivery Solutions Business Overview
  88. 6.15.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Portfolio
  90. 6.15.5 Athena Drug Delivery Solutions Recent Developments
  91. 6.16 Advicenne
  92. 6.16.1 Advicenne Company Information
  93. 6.16.2 Advicenne Business Overview
  94. 6.16.3 Advicenne GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Advicenne GABA Receptor Agonist Drug Product Portfolio
  96. 6.16.5 Advicenne Recent Developments
7 North America by Country
  1. 7.1 North America GABA Receptor Agonist Drug Sales by Country
  2. 7.1.1 North America GABA Receptor Agonist Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America GABA Receptor Agonist Drug Sales by Country (2021-2026)
  4. 7.1.3 North America GABA Receptor Agonist Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America GABA Receptor Agonist Drug Market Size by Country
  6. 7.2.1 North America GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America GABA Receptor Agonist Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America GABA Receptor Agonist Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe GABA Receptor Agonist Drug Sales by Country
  2. 8.1.1 Europe GABA Receptor Agonist Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe GABA Receptor Agonist Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe GABA Receptor Agonist Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe GABA Receptor Agonist Drug Market Size by Country
  6. 8.2.1 Europe GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe GABA Receptor Agonist Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe GABA Receptor Agonist Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific GABA Receptor Agonist Drug Sales by Country
  2. 9.1.1 Asia-Pacific GABA Receptor Agonist Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific GABA Receptor Agonist Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific GABA Receptor Agonist Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific GABA Receptor Agonist Drug Market Size by Country
  6. 9.2.1 Asia-Pacific GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific GABA Receptor Agonist Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific GABA Receptor Agonist Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America GABA Receptor Agonist Drug Sales by Country
  2. 10.1.1 South America GABA Receptor Agonist Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America GABA Receptor Agonist Drug Sales by Country (2021-2026)
  4. 10.1.3 South America GABA Receptor Agonist Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America GABA Receptor Agonist Drug Market Size by Country
  6. 10.2.1 South America GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America GABA Receptor Agonist Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America GABA Receptor Agonist Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa GABA Receptor Agonist Drug Sales by Country
  2. 11.1.1 Middle East and Africa GABA Receptor Agonist Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa GABA Receptor Agonist Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa GABA Receptor Agonist Drug Market Size by Country
  6. 11.2.1 Middle East and Africa GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa GABA Receptor Agonist Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa GABA Receptor Agonist Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 GABA Receptor Agonist Drug Value Chain Analysis
  2. 12.1.1 GABA Receptor Agonist Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 GABA Receptor Agonist Drug Production Mode & Process
  7. 12.2 GABA Receptor Agonist Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 GABA Receptor Agonist Drug Distributors
  10. 12.2.3 GABA Receptor Agonist Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst